billS5004Event Wednesday, July 15, 2026Analyzed

A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.

Neutral

Summary

S5004, introduced by Sen. Smith (D-MN) with one cosponsor, would require group health plans to offer cost-sharing for oral anticancer drugs no less favorable than for IV anticancer drugs. The bill is in early legislative stage—referred to committee—and has no direct funding mechanism. No immediate market impact is expected given the procedural status and low likelihood of near-term passage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.S5004 is a procedural bill with no funding and early-stage congressional status.
  • 2.The mandate would affect group health plans, but the impact is limited by existing state parity laws and low legislative momentum.
  • 3.No specific publicly traded companies are directly and immediately affected; the bill is a monitoring item, not a trading signal.

Market Implications

The bill's introduction does not alter the current market outlook for healthcare companies. For pharmaceutical firms with oral oncology drugs ($PFE, $ABBV, $LLY, $JNJ), the potential for increased utilization is distant and contingent on passage. For health insurers ($UNH, $HUM), the cost impact is minor and likely already priced into existing state-level parity requirements. No market movement is expected from this single legislative action.

Full Analysis

On July 15, 2026, Sen. Tina Smith (D-MN) introduced S5004, a bill to amend ERISA to mandate that group health plans (and associated health insurance coverage) provide cost-sharing for oral anticancer drugs on terms no less favorable than for anticancer medications administered by a health care provider. The bill was read twice and referred to the Committee on Health, Education, Labor, and Pensions. With only one cosponsor (Sen. Jerry Moran, R-KS), the bill has limited bipartisan support at this stage. The legislative hurdle is significant: the bill must pass committee, the full Senate, and the House before becoming law. No funding is authorized or appropriated; the bill imposes a regulatory mandate on private health plans. The primary affected sector is Healthcare, specifically health insurers and pharmaceutical companies that manufacture oral anticancer drugs. However, the bill is early-stage and procedural; its passage probability is low. Market participants should monitor committee activity and potential hearings, but no near-term financial impact is anticipated. The bill does not change existing coverage requirements—it only equalizes cost-sharing for drugs already covered. Many plans already comply with similar state-level parity laws, reducing the incremental effect.

Key Legislators

Sen. Smith, Tina [D-MN]

Connected Signals

Matched on shared policy language across AI analyses, with ticker & timing weight

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderSep 18, 2026

Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program

This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →